Stay updated on Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the Conditions list and a Genetic and Rare Diseases Information Center resource was linked in Resources. The page revision is updated to v3.4.2 from v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-14T05:11:05.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed, which are minor UI/version changes not affecting study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T04:46:29.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Show glossary was added; update-related items (Last Update Submitted that Met QC Criteria and Last Update Posted) are displayed, and the page revision updated to Revision: v3.4.0, while older labeling such as No FEAR Act data and the previous revision text were removed.
    Difference
    0.1%
    Check dated 2026-01-23T22:35:49.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page metadata now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-17T01:33:18.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Recruitment status for NCT05445778 was updated to Completed on 2026-01-07, replacing the prior Recruiting status recorded in 2025.
    Difference
    0.5%
    Check dated 2026-01-10T02:04:05.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Recruitment locations have been expanded and reorganized across numerous regions and countries, with many new sites added and some existing sites removed. This changes where participants may enroll in the study.
    Difference
    4%
    Check dated 2025-12-19T15:20:15.000Z thumbnail image

Stay in the know with updates to Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.